VEGF-B promotes cancer metastasis through a VEGF-A–independent mechanism and serves as a marker of poor prognosis for cancer patients
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
VEGF-B promotes cancer metastasis through a VEGF-A–independent mechanism and serves as a marker of poor prognosis for cancer patients
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 112, Issue 22, Pages E2900-E2909
Publisher
Proceedings of the National Academy of Sciences
Online
2015-05-20
DOI
10.1073/pnas.1503500112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer
- (2014) Michael Y Bonner et al. Future Medicinal Chemistry
- Vascular endothelial growth factor-dependent spatiotemporal dual roles of placental growth factor in modulation of angiogenesis and tumor growth
- (2013) Xiaojuan Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-VEGF- and anti-VEGF receptor-induced vascular alteration in mouse healthy tissues
- (2013) Y. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases
- (2012) Jack L. Arbiser et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs
- (2012) E.-M. E. Hedlund et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-Invasive Adjuvant Therapy with Imipramine Blue Enhances Chemotherapeutic Efficacy Against Glioma
- (2012) J. M. Munson et al. Science Translational Medicine
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Pathological angiogenesis facilitates tumor cell dissemination and metastasis
- (2011) Pegah Rouhi et al. CELL CYCLE
- Forty-Year Journey of Angiogenesis Translational Research
- (2011) Y. Cao et al. Science Translational Medicine
- Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis
- (2010) Suphansa Sawamiphak et al. NATURE
- Hypoxia-induced metastasis model in embryonic zebrafish
- (2010) Pegah Rouhi et al. Nature Protocols
- Suppressive Effects of Vascular Endothelial Growth Factor-B on Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Tumorigenesis
- (2010) Imke Albrecht et al. PLoS One
- Optimizing the Delivery of Cancer Drugs That Block Angiogenesis
- (2010) Y. Cao et al. Science Translational Medicine
- VEGF-B
- (2010) Xuri Li et al. Cell Adhesion & Migration
- Nitric oxide permits hypoxia-induced lymphatic perfusion by controlling arterial-lymphatic conduits in zebrafish and glass catfish
- (2009) L. Dahl Ejby Jensen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis
- (2009) F. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model
- (2009) S. L. C. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Positive and Negative Modulation of Angiogenesis by VEGFR1 Ligands
- (2009) Y. Cao Science Signaling
- Resolution of Non–Small-Cell Lung Cancer after Withdrawal of Anti-TNF Therapy
- (2008) Charles W. Lees et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started